Oppenheimer Remains Sidelined on UiPath Inc. (PATH), 'FY2024 ARR guidance implies that this reported metric will continue declining and remains a stock overhang'
March 16, 2023 5:17 AM
Oppenheimer analyst Brian Schwartz reiterated a Perform rating and {REMOVEPT} price target on UiPath Inc. (NYSE: PATH).The analyst comments "UiPath’s ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
